As part of the country’s Ebola preparation response, Burundi launched an Ebola vaccination campaign on August 13—delivering Merck’s rVSV-ZEBOV vaccine to health workers and frontline staff located at border entry points with the Democratic Republic of Congo (DRC). The vaccine was shown to be effective and safe during outbreaks in DRC’s North Kivu and Ituri provinces in April. WHO; WHO
Menu